Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1986-1-6
|
pubmed:abstractText |
The metabolism and receptor binding of nandrolone (N) and testosterone (T) were studied under in vitro and in vivo conditions. The results of both in vitro incubation studes with 3H-N and 3H-T in tissue homogenates from rats and in vivo infusion studies with 3H-N and 3H-T in conscious rats show the importance of the enzymes 5 alpha-reductase and 3 alpha/beta-hydroxysteroid-oxidoreductases in the prostate and the importance of the enzyme 17 beta-hydroxysteroid dehydrogenase in the kidney for the effects of N and T on these tissues. Following infusion of a combined dose of 3H-N and 3H-T there is a preferential retention at the receptor of 5 alpha-dihydrotestosterone (DHT) over 5 alpha-dihydronandrolone (DHN), N and T (DHT much greater than DHN greater than N greater than T) in the prostate because T is a better substrate than N for 5 alpha-reductase and because DHT binds more strongly to the androgen receptor than DHN, N and T. In the kidney 5 alpha-reductase is not important; there is a preferential retention of N in T (DHN and DHT were only present in small amounts) because N is less susceptible than T for metabolic inactivation by the enzyme 17 beta-hydroxysteroid dehydrogenase and N binds strongly to the androgen receptor. Both in vitro and in vivo studies show that N and T were relatively stable in spleen, thymus and muscular tissue (only shown in vivo) and, as a result, the same amount of N and T was bound to the receptor in these tissues in the in vivo infusion experiment.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholestenone 5 alpha-Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Nandrolone,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tritium
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9750
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-7
|
pubmed:dateRevised |
2008-2-12
|
pubmed:meshHeading |
pubmed-meshheading:3865479-Animals,
pubmed-meshheading:3865479-Cholestenone 5 alpha-Reductase,
pubmed-meshheading:3865479-Humans,
pubmed-meshheading:3865479-Male,
pubmed-meshheading:3865479-Nandrolone,
pubmed-meshheading:3865479-Oxidoreductases,
pubmed-meshheading:3865479-Rats,
pubmed-meshheading:3865479-Rats, Inbred Strains,
pubmed-meshheading:3865479-Receptors, Androgen,
pubmed-meshheading:3865479-Testosterone,
pubmed-meshheading:3865479-Tritium
|
pubmed:year |
1985
|
pubmed:articleTitle |
Metabolism and receptor binding of nandrolone and testosterone under in vitro and in vivo conditions.
|
pubmed:publicationType |
Journal Article,
In Vitro
|